Provided by Tiger Trade Technology Pte. Ltd.

Biogen

216.78
+2.431.13%
Post-market: 216.780.00000.00%19:30 EDT
Volume:722.35K
Turnover:156.95M
Market Cap:32.00B
PE:38.50
High:219.12
Open:217.76
Low:215.00
Close:214.35
52wk High:222.15
52wk Low:131.52
Shares:147.64M
Float Shares:147.31M
Volume Ratio:1.01
T/O Rate:0.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.63
EPS(LYR):8.79
ROE:4.58%
ROA:5.21%
PB:1.70
PE(LYR):24.66

Loading ...

Agios Q2 Revenue Jumps on US Commercial Launch of Aqvesme

Reuters
·
Jul 30

U.S. Research ROUNDUP-Equinix, Meta, S&P Global

Reuters
·
Jul 30

Biogen : TD Cowen Raises Target Price to $225 from $215

THOMSON REUTERS
·
Jul 30

Analysts’ Top Healthcare Picks: Icon (ICLR), Biogen (BIIB)

TIPRANKS
·
Jul 30

Viking Therapeutics Reports Q2 Milder-than-expected Net Loss as Obesity Trials Advance

Reuters
·
Jul 30

Corcept Therapeutics Q2 Revenue Estimates, Raises 2026 Outlook

Reuters
·
Jul 30

Biogen Boosts Profit Forecast with Growth Across Alzheimer's, Rare Disease Portfolio

Benzinga Earnings
·
Jul 30

Analysts Conflicted on These Healthcare Names: Biogen (BIIB), NeuroPace (NPCE) and Gilead Sciences (GILD)

TIPRANKS
·
Jul 30

Wedbush Adjusts Biogen Price Target to $215 From $201, Maintains Neutral Rating

MT Newswires Live
·
Jul 30

Stifel Nicolaus Adjusts Biogen Price Target to $242 From $214

MT Newswires Live
·
Jul 30

Analysts Offer Insights on Healthcare Companies: Biogen (BIIB) and Dyne Therapeutics (DYN)

TIPRANKS
·
Jul 29

Biogen's Q2 Results Beat Boosted By Apellis Acquisition, Wedbush Says

MT Newswires Live
·
Jul 29

U.S. stock movers: Q2 revenue and earnings per share beat expectations, Biogen (BIIB.US) climbs over 5%

Stock News
·
Jul 29

Is Biogen (BIIB) Undervalued Following Its Q2 2026 Earnings?

Simply Wall St.
·
Jul 29

Stock Track | Biogen Soars 5% Intraday as Q2 Earnings and Revenue Beat, Growth Portfolio Drives Outlook Raise

Stock Track
·
Jul 29

Biogen Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 29

Biogen CEO Says Co Expects to be Less Intentional and More Opportunistic About M&a -Conf Call

THOMSON REUTERS
·
Jul 29

Analysts Offer Insights on Healthcare Companies: Biogen (BIIB), Quest Diagnostics (DGX) and Otsuka Holdings Co (OtherOTSKF)

TIPRANKS
·
Jul 29

Old product decline offset by new launches: acquisition-driven transformation shows results, Biogen (BIIB.US) raises full-year revenue outlook

Stock News
·
Jul 29

Biogen is Maintained at Equal-Weight by Barclays

Dow Jones
·
Jul 29